Skip to main content
Caplight Logo









Koniku

Koniku

Private
San Rafael, CaliforniaFrontier & Industrial Techhttps://koniku.com/

Last Round

Series A

Dec 17, 2021

Total Funding Raised

$1.76M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Koniku is a biotechnology company that develops neurotechnology devices, including its flagship 'Konikore' wetware chip, which integrates live biological neurons with silicon to provide advanced odor positioning and surveillance systems.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Sensors, Defense Tech, Aviation & Drones

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Infrastructure

Keywords

biosensorsynthetic biologysmell cyborgwetwareodor detectionthreat detectionvolatile organic compoundsVOCaviation securityelectronic nosebio-electronic sensorchemical sensingcomputational neurosciencedeep tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Koniku Comparables

Compare Koniku with similar companies based on industry and business-model similarity.

Koniku comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tracense Systems
74%
Smiths Group
70%
AIRSENSE Analytics
70%

Koniku Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ADec 17, 2021
AcceleratorOct 20, 2016
SeedAug 12, 2016
AcceleratorSep 19, 2015
GrantMar 27, 2015

Key People

Founding team and executive leadership

Osh .

Founder, CEO & CTO

Founding Team

Koniku Investors

Notable investors and investment history

Koniku investors
InvestorRounds
Platform CapitalSeries A
MIT Global Startup WorkshopGrant
Plug and Play Tech CenterAccelerator, Seed
Andon OkapiSeries A
SoftBank GroupSeries A
Presight CapitalSeries A
IndieBioSeed, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 81% MoM.

  • Jul 27, 2026

    Monthly visitors grew 65% MoM, from 742 to 1.2K.

Koniku Filings

Explore SEC and related filing metadata, where available.

Koniku filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Koniku's valuation, stock price, and market status.

Is Koniku a public or private company?

Koniku is a private company.

What is the current stock price of Koniku?

Koniku is a private company, so its shares have no public market price. Caplight tracks Koniku's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Koniku worth (valuation)?

Valuation information for Koniku is not publicly available.

Can I buy Koniku stock?

Koniku shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Koniku's last funding round?

Koniku's most recent funding round was Series A on December 17, 2021.

Who are the main investors in Koniku?

Key investors in Koniku include Platform Capital, IndieBio, Oriza Ventures, Plug and Play APAC.

Will Koniku IPO soon?

No public IPO plans have been announced for Koniku.

How can I track Koniku secondary market activity?

Caplight tracks bids, offers, and trades in Koniku's shares on secondary markets.

Firmographic Details

HeadquartersSan Rafael, California
Employee Range6
Year Founded2015
Last FundingDec 17, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?